Exercise Mode Specificity for Preserving Spine and Hip Bone Mineral Density in Prostate Cancer Patients.


Journal

Medicine and science in sports and exercise
ISSN: 1530-0315
Titre abrégé: Med Sci Sports Exerc
Pays: United States
ID NLM: 8005433

Informations de publication

Date de publication:
04 2019
Historique:
pubmed: 6 11 2018
medline: 18 12 2019
entrez: 6 11 2018
Statut: ppublish

Résumé

Androgen deprivation therapy (ADT) in men with prostate cancer (PCa) is associated with an array of adverse effects, including reduced bone mineral density (BMD) predisposing patients to increased fracture risk. Our purpose was to examine the effects of targeted exercise modes on BMD in men with PCa undergoing ADT. Between 2009 and 2012, 154 PCa patients 43-90 yr old on ADT were randomized to exercise targeting the musculoskeletal system (impact loading + resistance training [ImpRes], n = 57) supervised for 12 months, cardiovascular and muscular systems (aerobic + resistance training, n = 50) supervised for 6 months followed by a 6-month home-based program, or delayed aerobic exercise (DelAer, n = 47) received exercise information for 6 months followed by 6 months of supervised aerobic exercise (stationary cycling). End points were lumbar spine, hip and whole-body BMD measured by dual-energy x-ray absorptiometry with secondary end points of lean and fat mass, appendicular skeletal muscle mass, and neuromuscular strength. ANOVA was used to compare the exercise groups with DelAer at 6 and 12 months. There was a between-group difference in BMD for ImpRes and DelAer at the spine (6 months, P = 0.039; 12 months, P = 0.035) and femoral neck (6 months, P = 0.050), with decline attenuated in ImpRes (~-1.0% vs ~-2.0%). Compared with DelAer, ImpRes increased appendicular skeletal muscle at 6 months (0.3 kg, P = 0.045) and improved muscle strength at 6 and 12 months (P ≤ 0.012) by 9%-34%. A limitation was inclusion of well-functioning patients. Combined impact loading and resistance exercise attenuates bone loss at the spine and enhances overall musculoskeletal function in PCa patients undergoing ADT.

Identifiants

pubmed: 30395051
doi: 10.1249/MSS.0000000000001831
doi:

Substances chimiques

Androgen Antagonists 0
Antineoplastic Agents, Hormonal 0

Types de publication

Clinical Trial, Phase III Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

607-614

Auteurs

Robert U Newton (RU)

Exercise Medicine Research Institute, Edith Cowan University, Joondalup, WA, AUSTRALIA.
School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, AUSTRALIA.
Institute of Human Performance, The University of Hong Kong, HONG KONG.
School of Human Movement and Nutrition Sciences, University of Queensland, Brisbane, QLD, AUSTRALIA.

Daniel A Galvão (DA)

Exercise Medicine Research Institute, Edith Cowan University, Joondalup, WA, AUSTRALIA.
School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, AUSTRALIA.

Nigel Spry (N)

Exercise Medicine Research Institute, Edith Cowan University, Joondalup, WA, AUSTRALIA.
Genesis CancerCare, Joondalup, WA, AUSTRALIA.
Faculty of Medicine, University of Western Australia, Nedlands, WA, AUSTRALIA.

David Joseph (D)

Exercise Medicine Research Institute, Edith Cowan University, Joondalup, WA, AUSTRALIA.
Faculty of Medicine, University of Western Australia, Nedlands, WA, AUSTRALIA.
Department of Radiation Oncology, Sir Charles Gairdner Hospital, Nedlands, WA, AUSTRALIA.

Suzanne K Chambers (SK)

Exercise Medicine Research Institute, Edith Cowan University, Joondalup, WA, AUSTRALIA.
Menzies Health Institute Queensland, Griffith University, Gold Coast, AUSTRALIA.
Centre for Research in Cancer Control, Cancer Council Queensland, Brisbane, QLD, AUSTRALIA.
Prostate Cancer Foundation of Australia, Sydney, NSW, AUSTRALIA.

Robert A Gardiner (RA)

Exercise Medicine Research Institute, Edith Cowan University, Joondalup, WA, AUSTRALIA.
School of Human Movement and Nutrition Sciences, University of Queensland, Brisbane, QLD, AUSTRALIA.
Department of Urology, Royal Brisbane and Women's Hospital, Brisbane, AUSTRALIA.

Brad A Wall (BA)

School of Psychology and Exercise Science, Murdoch University, Murdoch, WA, AUSTRALIA.

Kate A Bolam (KA)

Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, SWEDEN.

Dennis R Taaffe (DR)

Exercise Medicine Research Institute, Edith Cowan University, Joondalup, WA, AUSTRALIA.
School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, AUSTRALIA.
School of Human Movement and Nutrition Sciences, University of Queensland, Brisbane, QLD, AUSTRALIA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH